CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-09-24

DOI:

10.1073/pnas.2519568122

Affiliations:

9

Authors:

24

Go to article

Institutions	Authors	Share
State Key Laboratory of Systems Medicine for Cancer, SJTU, China	12.000000 12.000000	0.50
Netherlands Cancer Institute (NKI), Netherlands	2.500000	0.10
Oncode Institute, Netherlands	2.500000	0.10
Huashan Hospital, Fudan University, China	2.000000	0.08
MOE Key Laboratory for Carcinogenesis and Invasion, China	1.500000	0.06
State Key Laboratory of Oncology in South China, SYSUCC, China	1.000000	0.04
Shanghai Jiao Tong University (SJTU), China	1.000000	0.04
Renji Hospital, SJTU, China	1.000000	0.04
State Key Laboratory of Cardiology, China	0.500000	0.02

Interested in Oncology and Carcinogenesis?